We are live on ! Find out more
Exane Derivatives

Exane Derivatives Portfolio holdings

AUM $174M Turnover 34.02%
1-Year Est. Return 7.84%
This Fund
S&P 500
This Quarter Est. Return
-14.18%
1 Year Est. Return
-7.84%
3 Year Est. Return
+42.72%
5 Year Est. Return
+56.28%
10 Year Est. Return
–
AUM
$174M
AUM Growth
-$181M
Cap. Flow
-$142M
Cap. Flow %
-81.48%
Top 10 Hldgs %
28.03%
Holding
1,070
New
55
Increased
89
Reduced
355
Closed
309
Avg Time Held Equity + Options
2.5 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
2.5 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.5 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 22.4%
2 Technology 15.03%
3 Healthcare 12.1%
4 Energy 10.33%
5 Industrials 6.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
HCAT icon
551
Health Catalyst
HCAT
$127M
$623 ﹤0.01%
43
– –
2020 Q4
6 quarters
LII icon
552
Lennox International
LII
$11.8B
$620 ﹤0.01%
3
-16
-84% -$3.5K
2021 Q1
5 quarters
INGR icon
553
Ingredion
INGR
$6.12B
$617 ﹤0.01%
7
– –
2016 Q4
22 quarters
FFIV icon
554
F5
FFIV
$19.2B
$612 ﹤0.01%
4
– –
2015 Q3
27 quarters
EPR icon
555
EPR Properties
EPR
$4.42B
$610 ﹤0.01%
13
+5
+63% +$253
2017 Q1
21 quarters
DOC icon
556
DELISTED
PHYSICIANS REALTY TRUST
DOC
$593 ﹤0.01%
34
– –
2019 Q4
10 quarters
KRG icon
557
Kite Realty
KRG
$5.02B
$588 ﹤0.01%
34
– –
2021 Q4
2 quarters
CLX icon
558
Clorox
CLX
$10.6B
$564 ﹤0.01%
4
– –
2020 Q2
8 quarters
GT icon
559
Goodyear
GT
$1.24B
$557 ﹤0.01%
52
– –
2020 Q1
9 quarters
AVIR icon
560
Atea Pharmaceuticals
AVIR
$330M
$554 ﹤0.01%
78
– –
2021 Q2
4 quarters
BURL icon
561
Burlington
BURL
$14.9B
$545 ﹤0.01%
4
– –
2019 Q3
11 quarters
RL icon
562
Ralph Lauren
RL
$23.4B
$538 ﹤0.01%
6
-36
-86% -$3.63K
2018 Q3
15 quarters
BDN icon
563
Brandywine Realty Trust
BDN
$500M
$530 ﹤0.01%
55
– –
2019 Q2
12 quarters
OXY icon
564
Occidental Petroleum
OXY
$64B
$530 ﹤0.01%
+9
New +$553
2022 Q2
0 quarters
PJP icon
565
Invesco Pharmaceuticals ETF
PJP
$580M
$525 ﹤0.01%
7
– –
2018 Q3
15 quarters
PGRE
566
DELISTED
Paramount Group
PGRE
$513 ﹤0.01%
71
– –
2019 Q2
12 quarters
EMB icon
567
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$13B
$512 ﹤0.01%
6
-6,380
-100% -$577K
2014 Q4
30 quarters
DECK icon
568
Deckers Outdoor
DECK
$10.9B
$511 ﹤0.01%
12
-2,268
-99% -$99K
2020 Q4
6 quarters
AUTL icon
569
Autolus Therapeutics
AUTL
$405M
$509 ﹤0.01%
180
– –
2019 Q2
12 quarters
PHR icon
570
Phreesia
PHR
$772M
$500 ﹤0.01%
20
– –
2020 Q3
7 quarters
QSR icon
571
Restaurant Brands International
QSR
$25.2B
$499 ﹤0.01%
10
– –
2020 Q4
6 quarters
HAS icon
572
Hasbro
HAS
$16.8B
$491 ﹤0.01%
6
– –
2018 Q1
17 quarters
PTCT icon
573
PTC Therapeutics
PTCT
$5.01B
$481 ﹤0.01%
12
-116
-91% -$4.07K
2019 Q4
10 quarters
CPB icon
574
Campbell Soup
CPB
$6.39B
$480 ﹤0.01%
10
– –
2018 Q3
15 quarters
LITE icon
575
Lumentum
LITE
$76.2B
$476 ﹤0.01%
6
-1,231
-100% -$105K
2021 Q2
4 quarters

Similar funds

Exane Derivatives's Q2 2022 Portfolio in Review

As of Q2 2022, Exane Derivatives held 1,070 positions worth $174M, down 51% from $355M the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Exane Derivatives withdrew a net $142M in Q2 2022, closing 309 positions and reducing 355 holdings. Its most notable exit was Amazon, an estimated $5.98M position sold in full.

By sector, the portfolio is most concentrated in Miscellaneous at 22% of assets, up from 18% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Exane Derivatives opened a new position in iShares Core US Aggregate Bond ETF worth $4.5M.

  • Exane Derivatives's largest Q2 2022 buy was iShares Core US Aggregate Bond ETF: 44,298 shares worth $4.5M.
  • Exane Derivatives added most to Dow Inc in Q2 2022, an estimated $1.28M increase.
  • Exane Derivatives's biggest Q2 2022 reduction was State Street Energy Select Sector SPDR ETF, cutting an estimated $4.74M.
  • Exane Derivatives fully exited Amazon in Q2 2022, selling an estimated $5.98M.
  • Exane Derivatives's ten largest holdings make up 28% of its $174M portfolio in Q2 2022.
  • Exane Derivatives opened 55 new positions and closed 309 in Q2 2022.
  • Exane Derivatives's portfolio value fell 51% quarter-over-quarter to $174M.

Based on Exane Derivatives's 13F filing for Q2 2022, filed 12 Jul 2022.